DE69918124D1 - Formulierungen zur transdermalen verabreichung von fenoldopam - Google Patents

Formulierungen zur transdermalen verabreichung von fenoldopam

Info

Publication number
DE69918124D1
DE69918124D1 DE69918124T DE69918124T DE69918124D1 DE 69918124 D1 DE69918124 D1 DE 69918124D1 DE 69918124 T DE69918124 T DE 69918124T DE 69918124 T DE69918124 T DE 69918124T DE 69918124 D1 DE69918124 D1 DE 69918124D1
Authority
DE
Germany
Prior art keywords
fenoldopam
transdermal administration
formulations
membrane
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69918124T
Other languages
English (en)
Other versions
DE69918124T2 (de
Inventor
Osdol W Van
M Crisologo
Il Yum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of DE69918124D1 publication Critical patent/DE69918124D1/de
Application granted granted Critical
Publication of DE69918124T2 publication Critical patent/DE69918124T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
DE69918124T 1998-07-24 1999-07-16 Zusammensetzungen und Vorrichtungen zur transdermalen Verabreichung von Fenoldopam Expired - Fee Related DE69918124T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9405998P 1998-07-24 1998-07-24
PCT/US1999/016083 WO2000004886A1 (en) 1998-07-24 1999-07-16 Formulations for the transdermal administration of fenoldopam

Publications (2)

Publication Number Publication Date
DE69918124D1 true DE69918124D1 (de) 2004-07-22
DE69918124T2 DE69918124T2 (de) 2004-10-21

Family

ID=22242614

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69918124T Expired - Fee Related DE69918124T2 (de) 1998-07-24 1999-07-16 Zusammensetzungen und Vorrichtungen zur transdermalen Verabreichung von Fenoldopam

Country Status (9)

Country Link
EP (1) EP1100476B1 (de)
JP (1) JP2002521324A (de)
AT (1) ATE269063T1 (de)
AU (1) AU5105699A (de)
DE (1) DE69918124T2 (de)
ES (1) ES2219037T3 (de)
HK (1) HK1036594A1 (de)
PT (1) PT1100476E (de)
WO (1) WO2000004886A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL265100B2 (en) 2016-08-31 2023-11-01 Taro Pharma Ind Topical formulations of phenoldopam for the treatment of skin problems
WO2020183322A1 (en) 2019-03-08 2020-09-17 Taro Pharmaceutical Industries Ltd. Stable topical compositions of fenoldopam

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197297A (en) * 1976-11-17 1980-04-08 Smithkline Corporation 6-Halo-7,8-dihydroxy-1-(hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepines
US5719197A (en) * 1988-03-04 1998-02-17 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
GB9009390D0 (en) * 1990-04-26 1990-06-20 Smith Kline French Lab Pharmaceutical compositions
JP2001517493A (ja) * 1997-09-26 2001-10-09 ノーヴェン ファーマシューティカルズ インコーポレイテッド 生体接着剤組成物及び活性薬剤の局所投与方法

Also Published As

Publication number Publication date
WO2000004886A1 (en) 2000-02-03
JP2002521324A (ja) 2002-07-16
AU5105699A (en) 2000-02-14
PT1100476E (pt) 2004-10-29
ES2219037T3 (es) 2004-11-16
EP1100476B1 (de) 2004-06-16
ATE269063T1 (de) 2004-07-15
HK1036594A1 (en) 2002-01-11
DE69918124T2 (de) 2004-10-21
EP1100476A1 (de) 2001-05-23

Similar Documents

Publication Publication Date Title
DE69637061D1 (de) Neue formulierungen zur transdermalen verabreichung von pergolid
CY2503B1 (en) Novel formulations for the transdermal administration of fluoxetine acetate and fluoxetine maleate.
MX9709162A (es) Composiciones mejoradas de la permeacion en la piel que usan lactilatos de acilo.
DK0934078T3 (da) Permeabilitetsfremmere til transdermal administrering af aktivstoffer, anordninger og fremgangsmåde til fremstilling deraf
ATE347879T1 (de) Transdermale pharmazeutische zusammensetzung zur wirkstoffverabreichung
WO2000048445A3 (de) Pharmazeutische zusammensetzung enthaltend desoxypeganin zur behandlung der nikotinabhängigkeit
ATE269063T1 (de) Formulierungen zur transdermalen verabreichung von fenoldopam
TWI265027B (en) Topical application of muscarinic analgesic drugs such as neostigmine
JO2492B1 (en) A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
ATE228843T1 (de) Verwendung von desoxypeganin zur behandlung von drogenabhängigkeit
ATE302010T1 (de) Pharmazeutische zusammensetzung, enthaltend desoxypeganin zur behandlung des alkoholismus
DE60112584D1 (de) Verfahren zur Herstellung einer flüssigen Dosierungseinheit und Kit
DK1216036T3 (da) Transdermal administration af N-(2,5-disubstitueret phenyl)-N'-(3-substitueret phenyl)-N'-methylguanidin
WO2001035927A3 (en) Topical application of muscarinic analgesic drugs such as neostigmine
RU2002123991A (ru) Способ лечения красного плоского лишая

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee